← FDA DRUG APPROVALS

FDA ANDA · ANDA075563

SOTALOL HYDROCHLORIDE

Sponsor: OXFORD PHARMS

APPLICATION
ANDA075563
TYPE
ANDA
ORIGINAL APPROVAL
2003-11-07
LATEST ACTION
2023-09-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 240MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 120MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 160MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 80MG · TABLET · ORAL

Approval history

2023-09-12Labeling · Supplement 24 · standardAP
2023-02-28Labeling · Supplement 22 · standardAP
2020-10-29Labeling · Supplement 18 · standardAP
2015-04-28Labeling · Supplement 7AP
2011-04-28Labeling · Supplement 6AP
2007-03-01Labeling · Supplement 3AP
2003-11-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →